Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum Toxin in Patients With Hereditary Spastic Paraplegia: a Randomized, Double-blind, Placebo-controlled, Crossover Study

NCT02604186 is registered in ClinicalTrials.gov with University of Campinas, Brazil as lead sponsor.

NCT NCT02604186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02604186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum Toxin in Patients With Hereditary Spastic Paraplegia: a Randomized, Double-blind, Placebo-controlled, Crossover Study
Lead sponsor
University of Campinas, Brazil
Phase
Phase 2/3
Overall status
Completed
Start date
March 9, 2016
Completion date
March 15, 2017
Enrollment
55 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary spastic paraplegia